Xeljanz Xr 00069-0502
Generic: Tofacitinib
Product NDC
00069-0502- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 21, 2020
- Listing Expires
- December 31, 2027
- Application
- NDA208246
Need to source Xeljanz Xr? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tofacitinib Citrate | 22 mg/1 |
Drug Class
Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitors [MoA]
Packaging Options(1)
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0502-30)